These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3696269)

  • 21. Low-dose transdermal estradiol for symptomatic perimenopause.
    Shulman LP; Harari D
    Menopause; 2004; 11(1):34-9. PubMed ID: 14716180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Transdermal estrogen substitution in the climacteric syndrome].
    Melchert F; Schenkel L; Asche H
    Med Monatsschr Pharm; 1988 Jan; 11(2):88-90. PubMed ID: 3357481
    [No Abstract]   [Full Text] [Related]  

  • 23. Plasma leptin in postmenopausal women with coronary artery disease: effect of transdermal 17beta-estradiol and intermittent medroxyprogesterone acetate.
    Os I; Os A; Abdelnoor M; Larsen A; Birkeland K; Westheim A
    Climacteric; 2003 Sep; 6(3):204-10. PubMed ID: 14567768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do different delivery systems of hormone therapy have different effects on psychological symptoms in surgically menopausal women? A randomized controlled trial.
    Baksu B; Baksu A; Göker N; Citak S
    Maturitas; 2009 Feb; 62(2):140-5. PubMed ID: 19179026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alternatives to oral estrogen replacement. Transdermal patches, percutaneous gels, vaginal creams and rings, implants, other methods of delivery.
    Baker VL
    Obstet Gynecol Clin North Am; 1994 Jun; 21(2):271-97. PubMed ID: 7936545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogen augments serotonergic activity in postmenopausal women.
    Halbreich U; Rojansky N; Palter S; Tworek H; Hissin P; Wang K
    Biol Psychiatry; 1995 Apr; 37(7):434-41. PubMed ID: 7786956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of the climacteric syndrome with a combination of estrone sulfate and estradiol. Preliminary report].
    Ruiz Moreno JA; Rubio Lotvin B; De Larios NM; Bolio Arista R
    Ginecol Obstet Mex; 1973 Sep; 34(203):273-9. PubMed ID: 4756182
    [No Abstract]   [Full Text] [Related]  

  • 28. The effects of transdermal estradiol and oral conjugated estrogens on haemostasis variables.
    Kroon UB; Silfverstolpe G; Tengborn L
    Thromb Haemost; 1994 Apr; 71(4):420-3. PubMed ID: 8052956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two routes of hormonal replacement therapy in symptomatic menopausal women after kidney transplantation.
    Pietrzak B; Wielgos M; Kaminski P; Bobrowska K
    Neuro Endocrinol Lett; 2006 Jun; 27(3):387-91. PubMed ID: 16816826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical application of estrogen replacement therapy.
    Quigley JP; Williams D
    Int J Fertil; 1986; 31(3 Suppl [ESTROGEN]):45-50. PubMed ID: 2906340
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of a novel vaginal ring delivering oestradiol acetate on climacteric symptoms in postmenopausal women.
    Buckler H; Al-Azzawi F;
    BJOG; 2003 Aug; 110(8):753-9. PubMed ID: 12892687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of estradiol and of estrone during repeated transdermal or oral administration of estradiol.
    Setnikar I; Rovati LC; Vens-Cappell B; Hilgenstock C
    Arzneimittelforschung; 1996 Aug; 46(8):766-73. PubMed ID: 9125276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subcutaneous hormone implants for the control of climacteric symptoms. A prospective study.
    Brincat M; Magos A; Studd JW; Cardozo LD; O'Dowd T; Wardle PJ; Cooper D
    Lancet; 1984 Jan; 1(8367):16-8. PubMed ID: 6140343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of oral continuous and transdermal cyclic 17-beta estradiol and norethindrone acetate replacement therapy on platelet aggregation in postmenopausal women.
    Kaplan PB; Gücer F; Sayin NC; Yüce MA; Yardim T
    J Reprod Med; 2002 Aug; 47(8):651-5. PubMed ID: 12216432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term hormone implant therapy--hormonal and clinical effects.
    Barlow DH; Abdalla HI; Roberts AD; Al Azzawi F; Leggate I; Hart DM
    Obstet Gynecol; 1986 Mar; 67(3):321-5. PubMed ID: 3945443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of cyclic estradiol valerate/levonorgestrel on periclimacteric syndrome and endometrial cytology.
    Castiglione A; Bierschwale M; Novoa O
    Clin Ther; 1985; 7(5):555-8. PubMed ID: 3931915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patch up the menopause.
    Lancet; 1988 Apr; 1(8590):861-2. PubMed ID: 2895367
    [No Abstract]   [Full Text] [Related]  

  • 38. Proceedings: The treatment of climacteric disorders with a combination of estradiol and testosterone--an outline of the pathogenesis of psychic symptoms in the climacterium.
    Navrátil J; Nováková D; Pichner J
    Act Nerv Super (Praha); 1975; 17(4):307-8. PubMed ID: 1221812
    [No Abstract]   [Full Text] [Related]  

  • 39. Oestrogen therapy for the menopause.
    Studd J; Watson N; Henderson A
    Br J Psychiatry; 1990 Dec; 157():931-2. PubMed ID: 2289110
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of hot flushes].
    Cibier-Raphaël V
    Soins Gynecol Obstet Pueric Pediatr; 1989 Mar; (94):I-II. PubMed ID: 2727866
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.